Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 666,564 shares at $16.97 ($11.0M) on 2024-08-05, disclosed to the SEC on 2024-08-07.
Scheduled sale ($11.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.47 | 94,344 | $1.6M | 14.1% |
| 2 | $16.47 | 94,444 | $1.6M | 14.1% |
| 3 | $16.47 | 94,444 | $1.6M | 14.1% |
| 4 | $16.47 | 94,344 | $1.6M | 14.1% |
| 5 | $16.53 | 131,541 | $2.2M | 19.8% |
| 6 | $16.53 | 131,541 |
| $2.2M |
| 19.8% |
| 7 | $16.87 | 100 | $2K | 0.0% |
| 8 | $16.97 | 12,903 | $219K | 2.0% |
| 9 | $16.97 | 12,903 | $219K | 2.0% |
| Total | $16.51 avg | 666,564 | $11.0M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |